These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13702758)

  • 61. [Studies on the passive hemagglutination reaction with typhoid antigen in psychiatric patients].
    Pawliszyn W; Teleśnicki S
    Przegl Lek; 1972; 29(9):804-7. PubMed ID: 5085116
    [No Abstract]   [Full Text] [Related]  

  • 62. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 63. Immune leukopenia in rabbits induced with typhoid Vi-vaccine.
    VULCHANOV VH; POPIVANOV R
    Z Immun exp ther; 1960 Nov; 120():295-309. PubMed ID: 13782271
    [No Abstract]   [Full Text] [Related]  

  • 64. THE MECHANISM OF THE EFFECT OF ADRENALINE ON IMMUNOGENESIS.
    YAO TS; LEE ZG
    Sci Sin; 1964 Jul; 13():1117-22. PubMed ID: 14196481
    [No Abstract]   [Full Text] [Related]  

  • 65. Typhoid fever: pathogenesis and immunologic control. 2.
    Hornick RB; Greisman SE; Woodward TE; DuPont HL; Dawkins AT; Snyder MJ
    N Engl J Med; 1970 Oct; 283(14):739-46. PubMed ID: 4916916
    [No Abstract]   [Full Text] [Related]  

  • 66. [The preparation and effectiveness of lactic acid killed typhoid vaccine].
    JANDL G
    Z Hyg Infektionskr; 1961; 147():539-68. PubMed ID: 14451093
    [No Abstract]   [Full Text] [Related]  

  • 67. ENHANCED SEROLOGIC RESPONSE OF LEPROMATOUS PATIENTS TO ANTITYPHOID VACCINATION.
    OLIVEIRADEALMEIDA J; BRANDAO H; GARCIADELIMA E
    Int J Lepr; 1964; 32():292-6. PubMed ID: 14227403
    [No Abstract]   [Full Text] [Related]  

  • 68. [Average titer of typhoid agglutinins in normal persons of the city of Salvador].
    TEIXEIRA R
    Hospital (Rio J); 1960 May; 57():959-63. PubMed ID: 13837307
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevention of development of carriers in typhoid and paratyphoid fever.
    Kilesso VA; Bilibin AF; Tendetnik YY; Kornilova II; Antonova IV; Musabayev IK; Nevsky MV; Kusminova ML; Vasilyeva AV
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):95-103. PubMed ID: 4196796
    [No Abstract]   [Full Text] [Related]  

  • 70. [Animal experiments on antibody formation following thymectomy in adult rabbits].
    Hempel HC; Grimm J; Schwarz ER; Hofmann K; Korn D
    Dtsch Gesundheitsw; 1969 Jul; 24(28):1304-7. PubMed ID: 4987620
    [No Abstract]   [Full Text] [Related]  

  • 71. Household demand for typhoid fever vaccines in Hue, Vietnam.
    Do GC; Whittington D; Le TK; Utomo N; Nguyen TH; Poulos C; Dang TD; Kim D; Nyamete A; Acosta C
    Health Policy Plan; 2006 May; 21(3):241-55. PubMed ID: 16581824
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Study of typhoid-paratyphoid vaccines obtained from bacterial extracts absorbed on mineral support. IV. Comparative immunobiological study of typhoid paratyphoid antigenic extracts absorbed on mineral support].
    TOMA S; BARBER C; SORU E; GRITAENCO V; BOGOKOWSKY B
    C R Seances Soc Biol Fil; 1957; 151(1):50-1. PubMed ID: 13447310
    [No Abstract]   [Full Text] [Related]  

  • 73. [Disappearance rate from the circulation of normal & immune rabbits of typhoid vaccine labeled with P32 & injected by intravenous route].
    PAOLETTI A; BUONINCONTRO L
    Ann Sanita Pubblica; 1958; 19(5):1019-31. PubMed ID: 13606657
    [No Abstract]   [Full Text] [Related]  

  • 74. [Preventive properties of immune sera as a criterium in the determination of immunogenic properties of typhoid cultures in vaccinal preparations].
    GINTSE LA
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Oct; 29(10):93-8. PubMed ID: 13626079
    [No Abstract]   [Full Text] [Related]  

  • 75. [Effects of cortisone and ACTH on the production of specific antibodies in animals immunized with absorbed antityphoid vaccine].
    PARDELLI L; TORRACCA G; TOSI E
    Minerva Pediatr; 1956 Jul; 8(27-28):880-4. PubMed ID: 13369299
    [No Abstract]   [Full Text] [Related]  

  • 76. Application of the quantitative bacteriaemia test according to Lipp in the determination of potency of typhoid antigens.
    RAUSS K; KETYI I
    Z Immun exp ther; 1962 Jul; 123():173-83. PubMed ID: 14490603
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A long-term evaluation of the efficacy of mapharsen and typhoid vaccine, including a comparison with penicillin, in the treatment of early syphilis.
    THOMAS EW; GLEESEN GA
    Am J Syph Gonorrhea Vener Dis; 1953 Sep; 37(5):458-65. PubMed ID: 13080556
    [No Abstract]   [Full Text] [Related]  

  • 79. [Laboratory test of the toxicity of anti-typhoid vaccines used in field studies].
    Spaun J; Davidson I; Olesen-Larsen S
    Bol Oficina Sanit Panam; 1966 Jul; 61(1):49-58. PubMed ID: 4226172
    [No Abstract]   [Full Text] [Related]  

  • 80. [A new hemagglutination reaction with the erythrocytes of typhoid patients].
    NAKAMURA S
    Jpn J Med Sci Biol; 1961 Aug; 50():390-6. PubMed ID: 14478158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.